Anatomical pathology Flashcards
General approach to endocrine and metabolism disorders
Recognise/think of possibility of endocrine disorder
Confirm quantitatively with testing
Investigate cause
Manage
Functions of endocrine organs
Growth, reproduction, energy metabolism, stress responses, electrolyte and water handling, mineral metabolism
Common symptoms in endocrine disorders
- weight change
- lethargy
- BP high or low
- fractures
- electrolyte/mineral changes
Clinical consequences of pituitary pathology
Mechanical:
- raised ICP
- bony erosion
- local pressure
Altered hormonal secretion:
- hyperpituitarism
- hypopituitarism
Hypopituitarism
Inadequate functional tissue
• Absence or destruction of pituitary Bssue
e.g. injury, ischaemia, infec/on, pressure from adjacent tumour,
Rathke’s cleA cyst, trauma, previous surgery or radiotherapy
• Sheehan’s syndrome: post partum hypopituitarism (enlarged ant pit during pregnancy, intra or post partum haemorrhage leads to ischaemia of pituitary)
• Simmond’s syndrome: hypopituitarism due to other causes
Lack of stimulus driving secreBon (e.g. hypothalamic disease)
Hyperfunc/on of one product may be associated with Hypofunc/on of others (as a result of ‘pressure’ atrophy), and pituitary hypofuncBon leads to secondary hypofuncBon of pituitary dependent endocrine glands (through feedback inhibiBon).
Hyperpituitarism
• Excess secretion of trophic hormones • Can be caused by: – Pituitary adenoma – Secondary hyperplasia – Pituitary carcinoma (rare) – Secretion of hormones by non-pituitary tumours – Hypothalamic disorders
Posterior pituitary syndromes
(1) Diabetes insipidus: passage of large volumes of dilute urine
2 main forms:
- central - decreased ADH secretion
- nephrogenic - ADH resistance in the kidney
(2) Syndrome of inappropriate ADH secretion
- resorption of XS amounts of water
- usually caused by ectopic ADH secretion
Clinical consequences of thyroid disease
Mechanical
• Thyroid enlargement = ‘goitre’ (unilateral, bilateral, localised, diffuse), usually not painful
• Compression effects (airway, oesophagus, large vessels, nerves)
Functional
• Hyperthyroidism
• Hypothyroidism
• Euthyroid
Examples of hyper plastic, neoplastic and inflammatory thyroid pathologies
Hyperplasia
– Diffuse / Graves (Autoimmune)
– Mul2nodular goitre / Nodular colloid goitre
Neoplasia
– Adenomas
• Follicular/HurthleCell/Other – Carcinomas
• Papillary/Follicular/Anaplastic/Medullary
Inflammatory
– Hashimoto (Autoimmune)
– Lymphocytic, Granulomatous (De Queryvain)
Cause of hypothyroidism
Defect anywhere in the hypothalamic-pituitary-thyroid axis
- iodine deficiency
- thyroiditis (hashimoto’s, lymphocytic)
Children: cretinism (iodine deficiency usually)
Adults: myxoedema (TSH raised if normal feedback inhibition is lost)
Hashimoto’s thyroiditis
Autoimmune disease - anti-TPO found
Symptoms and signs of hyperthyroidism
Symptoms:
– Nervousness, Anxiety, Increasedperspiration, – Heat intolerance, Hyperactivity,
– Palpitations
Signs
– Tachycardia or atrial arrhythmia
– Systolic hypertension with wide pulse pressure
– Warm, moist, smooth skin
– Lid lag
– Stare
– Hand tremor
– Muscle weakness
– Weight loss despite increased appetite (although a few patients may gain weight, if excessive intake outstrips weight loss)
– Reduction in menstrual flow or oligomenorrhea
Most common causes of hyperthyroidism
- Grave’s disease
- Multi nodular goitre (hyper functional)
- thyroid adenoma (hyper functional)
Grave’s disease antibodies and diagnosis
Auto-antibodies against TSH receptor and other thyroid antibodies
- presence of these antibodies indicates Grave’s
Actions of PTH
Bone resorption
Renal tubular resorption of calcium
Increases conversion of Vit D to active (hydroxy) form in kidney
With Vitamin D, promotes calcium resorption from small intestine
Increases urinary phosphate excretion causing phosphaturia
Net effect is to increase serum calcium
Common cause of chronic hypocalcaemia
Usually due to chronic renal failure, vitamin D deficiency, drugs or intestinal malabsorption of calcium
Signs/symptoms of hypocalcaemia
Convulsions, arrhythmias, tetany, numbness and parasthesia, cramps, fatigue, depression, altered cognition
Most common causes of hypercalcaemia and clinical manifestations
- hyperparathyroidism
- hypercalcaemia of malignancy - adenoma
Clinical - renal stones, bones (pain, arthritis), groans (confusions, lethargy, weakness) and moans (nausea, vomiting, weight gain or anorexia, pain)
4 Classifications of hyperparathyroidism
Primary HP: XS PTH production
Secondary HP: other disease process drives increased PTH levels
Tertiary HP: autonomous PTH secretion, caused by longstanding secondary HP
Ectopic secretion - paraneoplastic from other malignancies
MEN syndromes in endocrine disorders
MEN-1 - loss of tumour suppressor gene, primary hyperparathyroidism (adenoma or hyperplasia)
MEN-2 - medullary thyroid carcinoma is main manifestation, usually due to RET protocol-oncogene mutation
6 types of cells in the Islet’s of Langherans and their function
- β – Insulin (regulates glucose in tissues, reduces blood glucose)
- α - Glucagon (stimulates glycogenolysis in the liver, increases blood sugar)
• δ – Somatostatin (suppresses both insulin and glucagon release)
• PP – secretes pancreatic polypeptide (stimulates gastric and intestinal enzymes and inhibits intestinal motility)
– Also
• D1 – Vasoactive intestinal polypeptide (VIP), induces glycogenolysis and hyperglycaemia
• Enterochromaffin cells – Serotonin
Diagnosis criteria for Diabetes
- Fasting plasma glucose ≥ 126 mg/dL,
- Random plasma glucose ≥ 200 mg/dL (in a patient with classic hyperglycemic signs),
- 2-hour plasma glucose ≥ 200 mg/dL during an oral glucose tolerance test (OGTT) with a loading dose of 75 gm
- Glycated hemoglobin (HbA1C) level ≥ 6.5%
Clinical presentation of T2DM vs T1
T1: indolent onset (years) but sudden presentation (decompensation)
Polyuria, polydipsia, polyphagia, subsequently DKA
T2: unexplained fatigue, dizziness, blurred vision, often asymptomatic and may become hyperosmolar non-ketotic state
Pathogenesis of T1DM
¥ Develops in childhood, manifests at puberty, progresses with age
¥ Without exogenous insulin patients become ketotic → coma → death
¥ Interplay of genetics (esp HLA-DR3 or HLA-DR4) and environment (still unclear)
¥ β cell destruction follows loss of self tolerance for T cells specific islet antigens (insulin receptor, GAD, others)
o Autoreactive T cells are not removed
o Are able to attack islets
Pathogenesis of T2DM
¥ Interplay of genetics (multiple loci, all small to moderate increase in risk) and environment (central/visceral obesity, sedentary lifestyle)
¥ Develops in adulthood, slow progression, initially high insulin but peripheral insulin resistance, later low insulin due to β cell dysfunction
¥ Insulin sensitivity decreases due to
o Free fatty acids
o Adipokines (secreted by adipocytes)
o Inflammation (pro-inflammatory cytokines secreted in response to nutrient excess)
¥ This results in β cell dysfunction develops later as cells exhaust their capacity to increase secretion
Two scenarios of gestational diabetes
o Patients with pre-existing DM may become pregnant
o Pregnancy may result in impaired glucose tolerance
Acute consequence more common in T1DM
DKA - insufficient insulin
Causes hyperglycaemia, osmotic diuresis and dehydration
Activates ketogenic pathway
Fatigue, nausea, vomiting, abdo pain, ketotic breath, laboured breathing, coma
Acute consequence more common in T2DM
Hyperosmolar hyperosmotic state: severe dehydration due to severe osmotic diuresis due to hyperglycaemia
Chronic conséquences of diabetes
Microvascular complications
Macrovascular complications
Predisposition to infection
Diabetic nephropathy
Macroangiopathy associated with diabetes
- accelerated atherosclerosis involving aorta + medium sized vessels
- widespread hyaline atherosclerosis
- MI most common cause of death
- gangrene of legs 100x more common in diabetics
Microangiopathy associated with diabetes
- diffuse thickening of basement membrane of capillaries
- in skin, muscles, retina, glomerulus
- poor wound healing
- underlies complications including diabetic nephropathy, retinopathy and some neuropathies
Aetiology of bladder cancer
- Cigarette smoking
- Occupational exposure; eg: aniline dyes
- Phenacetin
- Drugs such as cyclophosphamide, exposure to radiation
- Chronic infections
b. Schistosoma Haematobium - Squamous cell carcinoma. Recurrent UTI, Calculi etc. - Arsenic
- Genetic alterations: chromosome 9 monosomy or deletions of 9p and 9 q as well as deletions of 17p, 13q, 11p and 14q. Second pathway – p53 mutations.
Clinical features of bladder cancer
- Painless gross haematuria.
- Clotting and painful micturition
- Dysuria, urgency and frequency.
- Hydronephrosis
- Palpable pelvic mass, lower extremity oedema
- Weight loss, abdominal or bone pain.
Imaging used to diagnose bladder cancer
US, IVU, CT, MRI; used for detection and staging
TNM classification
¥ Ta – non invasive papillary carcinoma
¥ Tis – carcinoma in situ
¥ T1- invades subepithelial connective tissue
¥ T2- invades muscle; T2a- superficial muscle, T2b- deep muscle
¥ T3 – invades perivesical tissue T3a – microscopically
T3b – macroscopically
¥ T4 – invades prostate, uterus, vagina (T4a), pelvic wall, abdominal wall (T4b).
¥ N – Regional lymph nodes.
¥ N1- metastasis in I LN 2cm or less in greatest dimension.
¥ N2 - >2cm but <5cm in one or multiple LNs.
¥ N3 - >5cm.
¥ M – Distant metastasis.
Grading of urothelial tumours
¥ Urothelial papilloma
¥ Urothelial neoplasm of low malignat potential
¥ Papillary carcinoma, low grade
¥ Papillary carcinoma, high grade
Treatment for localised papillary low grade tumour
Transurethral resection
Treatment for high grade papillary tumours, multifocal, rapid recurrence
Intravesical BCG therapy
Treatment for tumour invading muscularis propria, extending to prostatic urethra/ducts
Radical cystectomy
Difference between invasive and non invasive urothelial tumours
Invasive - invades the lamina propria/muscularis propria
Non-invasive is limited to the epithelium
Grading of urothelial tumours - 4
¥ Urothelial papilloma
¥ Urothelial neoplasm of low malignant potential
¥ Papillary carcinoma, low grade
¥ Papillary carcinoma, high grade
Benign tumours of the kidney
¥ Renal papillary adenoma
¥ Renal fibroma or Hamartoma
¥ Juxtaglomerular cell tumour
¥ Angiomyolipoma
¥ Oncocytoma
Malignant tumours of the kidney
¥ Renal cell carcinoma: Clear cell renal cell carcinoma, papillary carcinoma, Chromophobe renal carcinoma, Collecting duct carcinoma, renal medullary carcinoma, Xp11translocation carcinoma, mucinous tubular and spindle cell carcinoma, multilocular clear cell renal cell carcinoma.
¥ Nephroblastoma
¥ Mesenchymal tumours – children and adults.
Clinical features for kidney tumours
¥ Haematuria
¥ Pain
¥ Flank mass
¥ Paraneoplastic syndromes: polycythemia, hypercalcemia etc
Most common renal tumour in childhood
Nephroblastoma